Navigation Links
Anti-anxiety treatment found effective in lowering blood pressure

Acute blood pressure (BP) increase is one of the most common causes for referral to the emergency room. In most patients the condition, although urgent, is not an emergency, and intravenous treatment is not required//. There are no guidelines on how to treat patients with acute BP elevation or excessive hypertension. Anxiety is a common cause of excessive hypertension and therefore antianxiety treatment may be beneficial in these patients.

Researchers from Israel suggest that it seems more physiologic to treat the cause of the BP increase rather than to use BP-lowering agents for all patients. Acute BP elevation may results due to a number of reasons, however, in many patients the cause of the BP elevation is unknown and panic attack or anxiety may be the cause. In these patients antianxiety treatment may be beneficial.

Researchers from the Tel Aviv University, Sackler School of Medicine, Israel, designed a study to compare the efficacy and safety of antianxiety treatment with the common practice of sublingual captopril administration in patients who were referred to the emergency room because of excessive hypertension without evidence of acute target organ damage. Thirty-six patients were randomized to receive either oral diazepam or sublingual captopril, Blood pressure (BP) and heart rate were recorded hourly for 3 h. Both treatments were found to decrease BP significantly in the study group.

The researchers, writing in the September issue of American Journal of Hypertension, conclude that antianxiety treatment is effective in lowering BP in patients with excessive hypertension. Thus, anxiolytic treatment may be considered in patients with excessive hypertension without acute target organ damage. However, further large placebo controlled studies are required to prove the benefit of anxiolytic agents. The researchers warn that despite the beneficial effect of antianxiety treatment it is important not to generalize the findings to all pati ents with excessive hypertension, as they were very careful to exclude patients with acute target organ impairment and patients with pains that required analgesics. Thus, this treatment should be reserved for patients who present with excessive BP values with no evidence of need for emergency treatment.
'"/>




Related medicine news :

1. Thyroid hormone treatment hastens recovery after cardiac surgery
2. Feeding channel created by malaria parasite - a new target for malaria treatments
3. Now umbilical cord helps in stroke treatment.
4. Now AIDS treatment comes dirt-cheap
5. Breast cancer treatment to be determined by gene test
6. Hemopurifier may revolutionise AIDS treatment
7. New drug helps boost cancer treatment
8. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
9. Experimental treatment for Ebola Virus Shows promising results in mice
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. New dimension in the treatment of female sexual dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2017)... Edmonton, AB (PRWEB) , ... July 21, 2017 , ... ... a life insurance brokerage firm servicing Albertans,” says owner and licensed broker Nerissa McNaughton. ... health insurance can be difficult, but it is a very necessary conversation. I make ...
(Date:7/21/2017)... ... , ... "As a doctor of lung medicine managing chest diseases for more ... said an inventor from Center Valley, Pa. "My idea is to improve the device ... the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an efficient means of draining pleural ...
(Date:7/21/2017)... Augusta, GA (PRWEB) , ... July 21, 2017 , ... ... is teaming up with the Epilepsy Foundation in a community wide charity event with ... region. , Delaney Sunde, a young local woman who lives with epilepsy, recently launched ...
(Date:7/21/2017)... Minnesota (PRWEB) , ... July 21, 2017 , ... ... BWBR recently were selected to renovate and improve the Ramsey County Medical Examiners ... adjacent to Regions Hospital, the $2.5 million project is scheduled to start in ...
(Date:7/21/2017)... ... July 21, 2017 , ... Hospital M&A activity slowed in the second quarter ... hospital acquisitions rose to 23 in the second quarter, up 15% from the 20 ... 20 announced deals in the year-ago second quarter. Only four of the transactions disclosed ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... Wash. , July 5, 2017   BioLife ... leading developer, manufacturer and marketer of proprietary clinical grade ... cryopreservation freeze media ("BioLife"), today announced that it ... its debt holder and largest shareholder, to modify its ... Pursuant to the modification, WAVI agreed to exchange ...
(Date:6/30/2017)... SAN DIEGO , June 30, 2017  AVACEN Medical (AVACEN) ... Access Journal. The research describes the use of its AVACEN ... by those suffering from fibromyalgia. ... AVACEN Medical ... Fibromyalgia is characterized by chronic widespread pain. It affects approximately 200 to ...
(Date:6/27/2017)... 27, 2017   NuEyes (NuEyes Technologies Inc.) today ... fuel its growth in helping the legally blind live more ... Group), the leading developer of augmented, virtual and mixed reality ... The undisclosed funding amount was provided by strategic partners ... with offices in Abu Dhabi , ...
Breaking Medicine Technology: